Chan Steveninsider trades

In SEC Form 4 filings, Chan Steven is listed as Chief Financial Officer of Attovia Therapeutics, Inc. (ATTO). Chan Steven reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 8.

Companies and roles

Company	Role	Transactions	Last filed
ATTOAttovia Therapeutics, Inc.	Chief Financial Officer	1	Oct 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-08

Dashed line = amended filing (Form 4/A)

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ATTOAttovia Therapeutics, Inc.	Aug 4	Oct 84/A	A · derivative	140,000	$17.00	$2,380,000	140,000	No	Form 4/A

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.